Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01545518
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:37.917877+00:00
Published At
2014-09-01T00:00:00+00:00
Record Updated At
2014-09-01
Results Posted At
2014-09-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Epilepsy, Cryptogenic", "Epilepsy, Partial", "Seizure Disorder", "Autoimmune Diseases, Nervous System", "Limbic Encephalitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-09-01"
protocolSection.identificationModule.nctId
"NCT01545518"
protocolSection.identificationModule.officialTitle
"IVIG Treatment for Refractory Immune-Related Adult Epilepsy"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-09-01"

Study condition terms

  • Epilepsy, Cryptogenic (protocolSection.conditionsModule.conditions)
  • Epilepsy, Partial (protocolSection.conditionsModule.conditions)
  • Seizure Disorder (protocolSection.conditionsModule.conditions)
  • Autoimmune Diseases, Nervous System (protocolSection.conditionsModule.conditions)
  • Limbic Encephalitis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.